AKT1 and cancer: These compounds induce cell cycle arrest and apoptosis and target critical cancer pathways, such as PI3K/AKT, mTOR, and FOXO transcription factors, thereby disrupting tumor growth and enhancing tumor sensitivity to therapies (30, 31).